Edition:
United Kingdom

Recro Pharma Inc (REPH.OQ)

REPH.OQ on NASDAQ Stock Exchange Capital Market

11.27USD
25 Apr 2018
Change (% chg)

$-0.41 (-3.51%)
Prev Close
$11.68
Open
$11.68
Day's High
$11.78
Day's Low
$11.18
Volume
45,712
Avg. Vol
50,524
52-wk High
$12.20
52-wk Low
$5.85

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.99 December 26 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 2 2 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.50 1.50 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 4 17.21 17.80 16.50 14.99
Quarter Ending Sep-18 4 18.03 18.30 17.80 14.97
Year Ending Dec-18 4 74.00 77.60 72.00 68.96
Year Ending Dec-19 5 110.82 121.80 102.50 109.54
Earnings (per share)
Quarter Ending Jun-18 4 -0.99 -0.56 -1.51 -0.51
Quarter Ending Sep-18 4 -0.73 -0.56 -0.79 -0.35
Year Ending Dec-18 4 -3.15 -2.43 -4.10 -2.77
Year Ending Dec-19 5 -1.47 -0.83 -2.43 -0.93

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 12.91 19.04 6.13 47.50
Quarter Ending Sep-17 13.68 17.11 3.43 25.08
Quarter Ending Jun-17 14.59 16.93 2.34 16.06
Quarter Ending Mar-17 15.16 18.74 3.58 23.62
Quarter Ending Dec-16 13.66 17.36 3.70 27.12

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 17.21 17.44 17.44 16.00 14.99
Quarter Ending Sep-18 18.03 18.05 18.05 16.52 14.97
Year Ending Dec-18 74.00 74.17 74.17 67.73 68.96
Year Ending Dec-19 110.82 111.68 111.68 111.66 109.54

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings